The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The report is about Sofosbuvir (CAS 1190307-88-0) API market.
The global Sofosbuvir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sofosbuvir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sofosbuvir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sofosbuvir include Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co and Hangzhou Longshine Bio-Tech Co, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sofosbuvir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sofosbuvir.
Report Scope
The Sofosbuvir market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sofosbuvir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sofosbuvir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO., LTD
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co., Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co
Segment by Type
Purity ≥ 98%
Purity ＜ 98%
Segment by Application
Adults Patients
Elderly Patients
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sofosbuvir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Sofosbuvir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Sofosbuvir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The report is about Sofosbuvir (CAS 1190307-88-0) API market.
The global Sofosbuvir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Sofosbuvir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sofosbuvir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Sofosbuvir include Teva Pharmaceutical Industries Ltd, DONG BANG FUTURE TECH & LIFE CO., LTD, Beaukev Pharma International Pvt.Ltd, DEAFARMA, Tecoland, Anhui HaiKang Pharmaceutical Co. Ltd, Shanghai Haoyuan Chemexpress Co., Ltd, Beijing Kawin Technology Share-holding Co and Hangzhou Longshine Bio-Tech Co, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sofosbuvir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sofosbuvir.
Report Scope
The Sofosbuvir market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sofosbuvir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sofosbuvir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries Ltd
DONG BANG FUTURE TECH & LIFE CO., LTD
Beaukev Pharma International Pvt.Ltd
DEAFARMA
Tecoland
Anhui HaiKang Pharmaceutical Co. Ltd
Shanghai Haoyuan Chemexpress Co., Ltd
Beijing Kawin Technology Share-holding Co
Hangzhou Longshine Bio-Tech Co
Segment by Type
Purity ≥ 98%
Purity ＜ 98%
Segment by Application
Adults Patients
Elderly Patients
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sofosbuvir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Sofosbuvir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Sofosbuvir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Sofosbuvir Market Overview
1.1 Product Definition
1.2 Sofosbuvir Segment by Type
1.2.1 Global Sofosbuvir Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 98%
1.2.3 Purity ＜ 98%
1.3 Sofosbuvir Segment by Application
1.3.1 Global Sofosbuvir Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Adults Patients
1.3.3 Elderly Patients
1.4 Global Market Growth Prospects
1.4.1 Global Sofosbuvir Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Sofosbuvir Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Sofosbuvir Production Estimates and Forecasts (2019-2030)
1.4.4 Global Sofosbuvir Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Sofosbuvir Production Market Share by Manufacturers (2019-2024)
2.2 Global Sofosbuvir Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Sofosbuvir, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Sofosbuvir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Sofosbuvir Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Sofosbuvir, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Sofosbuvir, Product Offered and Application
2.8 Global Key Manufacturers of Sofosbuvir, Date of Enter into This Industry
2.9 Sofosbuvir Market Competitive Situation and Trends
2.9.1 Sofosbuvir Market Concentration Rate
2.9.2 Global 5 and 10 Largest Sofosbuvir Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Sofosbuvir Production by Region
3.1 Global Sofosbuvir Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Sofosbuvir Production Value by Region (2019-2030)
3.2.1 Global Sofosbuvir Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Sofosbuvir by Region (2025-2030)
3.3 Global Sofosbuvir Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Sofosbuvir Production by Region (2019-2030)
3.4.1 Global Sofosbuvir Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Sofosbuvir by Region (2025-2030)
3.5 Global Sofosbuvir Market Price Analysis by Region (2019-2024)
3.6 Global Sofosbuvir Production and Value, Year-over-Year Growth
3.6.1 North America Sofosbuvir Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Sofosbuvir Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Sofosbuvir Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Sofosbuvir Production Value Estimates and Forecasts (2019-2030)
4 Sofosbuvir Consumption by Region
4.1 Global Sofosbuvir Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Sofosbuvir Consumption by Region (2019-2030)
4.2.1 Global Sofosbuvir Consumption by Region (2019-2024)
4.2.2 Global Sofosbuvir Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Sofosbuvir Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Sofosbuvir Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Sofosbuvir Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Sofosbuvir Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Sofosbuvir Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Sofosbuvir Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Sofosbuvir Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Sofosbuvir Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Sofosbuvir Production by Type (2019-2030)
5.1.1 Global Sofosbuvir Production by Type (2019-2024)
5.1.2 Global Sofosbuvir Production by Type (2025-2030)
5.1.3 Global Sofosbuvir Production Market Share by Type (2019-2030)
5.2 Global Sofosbuvir Production Value by Type (2019-2030)
5.2.1 Global Sofosbuvir Production Value by Type (2019-2024)
5.2.2 Global Sofosbuvir Production Value by Type (2025-2030)
5.2.3 Global Sofosbuvir Production Value Market Share by Type (2019-2030)
5.3 Global Sofosbuvir Price by Type (2019-2030)
6 Segment by Application
6.1 Global Sofosbuvir Production by Application (2019-2030)
6.1.1 Global Sofosbuvir Production by Application (2019-2024)
6.1.2 Global Sofosbuvir Production by Application (2025-2030)
6.1.3 Global Sofosbuvir Production Market Share by Application (2019-2030)
6.2 Global Sofosbuvir Production Value by Application (2019-2030)
6.2.1 Global Sofosbuvir Production Value by Application (2019-2024)
6.2.2 Global Sofosbuvir Production Value by Application (2025-2030)
6.2.3 Global Sofosbuvir Production Value Market Share by Application (2019-2030)
6.3 Global Sofosbuvir Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Teva Pharmaceutical Industries Ltd
7.1.1 Teva Pharmaceutical Industries Ltd Sofosbuvir Corporation Information
7.1.2 Teva Pharmaceutical Industries Ltd Sofosbuvir Product Portfolio
7.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served
7.1.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.2 DONG BANG FUTURE TECH & LIFE CO., LTD
7.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Corporation Information
7.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Product Portfolio
7.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Main Business and Markets Served
7.2.5 DONG BANG FUTURE TECH & LIFE CO., LTD Recent Developments/Updates
7.3 Beaukev Pharma International Pvt.Ltd
7.3.1 Beaukev Pharma International Pvt.Ltd Sofosbuvir Corporation Information
7.3.2 Beaukev Pharma International Pvt.Ltd Sofosbuvir Product Portfolio
7.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Beaukev Pharma International Pvt.Ltd Main Business and Markets Served
7.3.5 Beaukev Pharma International Pvt.Ltd Recent Developments/Updates
7.4 DEAFARMA
7.4.1 DEAFARMA Sofosbuvir Corporation Information
7.4.2 DEAFARMA Sofosbuvir Product Portfolio
7.4.3 DEAFARMA Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.4.4 DEAFARMA Main Business and Markets Served
7.4.5 DEAFARMA Recent Developments/Updates
7.5 Tecoland
7.5.1 Tecoland Sofosbuvir Corporation Information
7.5.2 Tecoland Sofosbuvir Product Portfolio
7.5.3 Tecoland Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Tecoland Main Business and Markets Served
7.5.5 Tecoland Recent Developments/Updates
7.6 Anhui HaiKang Pharmaceutical Co. Ltd
7.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Corporation Information
7.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Product Portfolio
7.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Main Business and Markets Served
7.6.5 Anhui HaiKang Pharmaceutical Co. Ltd Recent Developments/Updates
7.7 Shanghai Haoyuan Chemexpress Co., Ltd
7.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Corporation Information
7.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Product Portfolio
7.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Main Business and Markets Served
7.7.5 Shanghai Haoyuan Chemexpress Co., Ltd Recent Developments/Updates
7.8 Beijing Kawin Technology Share-holding Co
7.8.1 Beijing Kawin Technology Share-holding Co Sofosbuvir Corporation Information
7.8.2 Beijing Kawin Technology Share-holding Co Sofosbuvir Product Portfolio
7.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Beijing Kawin Technology Share-holding Co Main Business and Markets Served
7.7.5 Beijing Kawin Technology Share-holding Co Recent Developments/Updates
7.9 Hangzhou Longshine Bio-Tech Co
7.9.1 Hangzhou Longshine Bio-Tech Co Sofosbuvir Corporation Information
7.9.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir Product Portfolio
7.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Hangzhou Longshine Bio-Tech Co Main Business and Markets Served
7.9.5 Hangzhou Longshine Bio-Tech Co Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Sofosbuvir Industry Chain Analysis
8.2 Sofosbuvir Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Sofosbuvir Production Mode & Process
8.4 Sofosbuvir Sales and Marketing
8.4.1 Sofosbuvir Sales Channels
8.4.2 Sofosbuvir Distributors
8.5 Sofosbuvir Customers
9 Sofosbuvir Market Dynamics
9.1 Sofosbuvir Industry Trends
9.2 Sofosbuvir Market Drivers
9.3 Sofosbuvir Market Challenges
9.4 Sofosbuvir Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
